The comparison between tirzepatide and semaglutide has become increasingly relevant for patients and doctors seeking the most effective weight loss treatment. The main difference is the mechanism of action: semaglutide acts only on the GLP-1 receptor, while tirzepatide acts on two receptors (GIP and GLP-1).
Comparative studies show tirzepatide (Mounjaro) can provide 20-25% body weight loss, while semaglutide (Ozempic/Wegovy) results in 15-20% loss.
This difference in efficacy can be explained by the dual action of tirzepatide on GIP and GLP-1 receptors.
Acompanhe seus exames e veja o impacto do protocolo nos biomarcadores.
Registrar no appSemaglutide is available in doses from 0.25mg to 2.4mg weekly. Tirzepatide ranges from 2.5mg to 15mg weekly. Both are administered by weekly subcutaneous injection.
Both medications start with low doses and increase gradually to minimize side effects. The escalation period varies from 4 to 16 weeks.
Acompanhe seus exames e veja o impacto do protocolo nos biomarcadores.
Registrar no appSide effects are similar: nausea, vomiting, diarrhea, and constipation. Cost varies significantly by region and availability.
Consult your doctor to determine which option is better for your specific weight loss case.
Rastreador de Exames de Sangue
Registre e acompanhe resultados laboratoriais ao longo do tempo. Veja como seu protocolo afeta seus biomarcadores — tudo em uma linha do tempo.
Aviso: Este conteúdo é apenas informativo e não substitui orientação médica profissional. Consulte sempre seu médico antes de iniciar, alterar ou interromper qualquer tratamento.
